<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="15272" end="15275" sStart="15185" offset="87" sid="r8.way.n.0209" wn="1" wnkey="way%1:07:01::" text="For instance, studies from two laboratories reported marked differences in the way the ? 2 -adrenergic receptor (? 2 -AR) activates ERK 1 and 2 in HEK-293 cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="31373" end="31377" sStart="null" offset="177" sid="r7.1.use.v.0335" wn="1" wnkey="use%2:34:01::" text="Mouse monoclonal antibodies raised against phosphorylated tyrosines (clone PY20 (1:2,000 dilution), Santa Cruz Biotechnology, Santa Cruz, CA) were used to identify tyrosine phosphorylated EGFR or ?-ORs." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="3764" end="3771" sStart="null" offset="11" sid="r8.suggest.v.0557" wn="3" wnkey="suggest%2:32:02::" text="These data suggest that the tyrosine phosphorylation of GPCRs may allow them to signal ERKs in the absence of RTK or FAK phosphorylation by acting as their own scaffolds." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="18716" end="18725" sStart="null" offset="181" sid="r8.suggest.v.0043" wn="3" wnkey="suggest%2:32:02::" text="Src has also been found to co-immunoprecipitate with the agonist-stimulated ? 2 -AR during the period of ERK activation [ 8 ] . Our previous work [ 11 13 ] suggested that a Src-like protein tyrosine kinase was primarily responsible for tyrosine phosphorylation of the ?-OR and ERK activation induced by DTLET when the receptor was expressed in CHO or HEK-293 cells, because both responses were blocked by the presence of 50 ?M PP1." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="18716" end="18725" sStart="null" offset="181" sid="r8.suggest.v.0043" wn="3" wnkey="suggest%2:32:02::" text="Src has also been found to co-immunoprecipitate with the agonist-stimulated ? 2 -AR during the period of ERK activation [ 8 ] . Our previous work [ 11 13 ] suggested that a Src-like protein tyrosine kinase was primarily responsible for tyrosine phosphorylation of the ?-OR and ERK activation induced by DTLET when the receptor was expressed in CHO or HEK-293 cells, because both responses were blocked by the presence of 50 ?M PP1." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="18716" end="18725" sStart="null" offset="181" sid="r8.suggest.v.0043" wn="3" wnkey="suggest%2:32:02::" text="Src has also been found to co-immunoprecipitate with the agonist-stimulated ? 2 -AR during the period of ERK activation [ 8 ] . Our previous work [ 11 13 ] suggested that a Src-like protein tyrosine kinase was primarily responsible for tyrosine phosphorylation of the ?-OR and ERK activation induced by DTLET when the receptor was expressed in CHO or HEK-293 cells, because both responses were blocked by the presence of 50 ?M PP1." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="18716" end="18725" sStart="null" offset="181" sid="r8.suggest.v.0043" wn="3" wnkey="suggest%2:32:02::" text="Src has also been found to co-immunoprecipitate with the agonist-stimulated ? 2 -AR during the period of ERK activation [ 8 ] . Our previous work [ 11 13 ] suggested that a Src-like protein tyrosine kinase was primarily responsible for tyrosine phosphorylation of the ?-OR and ERK activation induced by DTLET when the receptor was expressed in CHO or HEK-293 cells, because both responses were blocked by the presence of 50 ?M PP1." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-2-5.anc" start="29738" end="29745" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="Immunoprecipitation of all receptor types was performed using magnetic Dynabeads (Dynal Bioscience, Lake &lt;b&gt;Success&lt;/b&gt;, NY) coated with anti-mouse or anti-rabbit IgG and used according to the manufacturer's instructions." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-2-5.anc" start="29738" end="29745" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="Immunoprecipitation of all receptor types was performed using magnetic Dynabeads (Dynal Bioscience, Lake &lt;b&gt;Success&lt;/b&gt;, NY) coated with anti-mouse or anti-rabbit IgG and used according to the manufacturer's instructions." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="22589" end="22595" sStart="null" offset="165" sid="r11.strong.j.0139" wn="1" wnkey="strong%3:00:00::" text="Functionally, these cells are no longer capable of activating ERK 1 or 2 in response to 10 ng/ml EGF (Figure), whereas this concentration produces a strong effect in non-pretreated cells." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-2-5.anc" start="24802" end="24807" sStart="null" offset="0" sid="null" wn="1" wnkey="serve%2:42:03::" text="These results demonstrate that opioid-mediated ERK activation occurs independently of EGFR transphosphorylation, and that the tyrosine-phosphorylated ?-OR may &lt;b&gt;serve&lt;/b&gt; as the primary scaffold." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="24802" end="24807" sStart="null" offset="183" sid="r7.serve.v.0697" wn="1" wnkey="serve%2:42:03::" text="These results demonstrate that opioid-mediated ERK activation occurs independently of EGFR transphosphorylation, and that the tyrosine-phosphorylated ?-OR may serve as the primary scaffold." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="2491" end="2497" sStart="null" offset="71" sid="r7.serve.v.0137" wn="1" wnkey="serve%2:42:03::" text="However, the question of what plasma membrane-spanning protein serves as the scaffold for Shc binding and beyond remains to be answered." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-2-5.anc" start="24802" end="24807" sStart="null" offset="0" sid="null" wn="1" wnkey="serve%2:42:03::" text="These results demonstrate that opioid-mediated ERK activation occurs independently of EGFR transphosphorylation, and that the tyrosine-phosphorylated ?-OR may &lt;b&gt;serve&lt;/b&gt; as the primary scaffold." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-2-5.anc" start="24802" end="24807" sStart="null" offset="0" sid="null" wn="1" wnkey="serve%2:42:03::" text="These results demonstrate that opioid-mediated ERK activation occurs independently of EGFR transphosphorylation, and that the tyrosine-phosphorylated ?-OR may &lt;b&gt;serve&lt;/b&gt; as the primary scaffold." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-2-5.anc" start="24802" end="24807" sStart="null" offset="0" sid="null" wn="1" wnkey="serve%2:42:03::" text="These results demonstrate that opioid-mediated ERK activation occurs independently of EGFR transphosphorylation, and that the tyrosine-phosphorylated ?-OR may &lt;b&gt;serve&lt;/b&gt; as the primary scaffold." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="20822" end="20832" sStart="null" offset="220" sid="r10.particular.j.0391" wn="2" wnkey="particular%5:00:02:specific:00" text="It is probable that the ?-OR in C6 glioma cells also acts as its own platform for the binding of Shc, etc., since the ?-OR also undergoes agonist-mediated tyrosine phosphorylation in this particular cell line (Kramer et al." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-2-5.anc" start="26058" end="26065" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="Insulin was obtained from University Hospital of New York University and PDGF was purchased from Biomol (Plymouth &lt;b&gt;Meeting&lt;/b&gt;, PA)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="11934" end="11940" sStart="null" offset="155" sid="r9.level.n.0749" wn="1" wnkey="level%1:07:00::" text="C6 glioma cells have been used as host cells for the transfection of several GPCR types, and have the advantage of expressing high levels of ERK, while being devoid of the EGFR." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="22915" end="22923" sStart="null" offset="75" sid="r11.function.n.0676" wn="3" wnkey="function%1:04:00::" text="This may represent a compensatory effect to counteract the loss of function of an important growth factor receptor." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="21991" end="21995" sStart="null" offset="209" sid="r9.fold.v.0060" wn="2147483646" wnkey="null" text="In the presence of the EGFR, ligand activation of LPA and ET-1 receptors did not increase EGFR phosphorylation even though both the LPA and ET-1 receptors stimulated ERK activity by 10-fold over basal [ 27 ] . Specifically, key protein intermediates may be physically associated with endogenous RTKs in HEK-293 cells, and therefore, down-regulation of the EGFR may negatively affect ERK phosphorylation by opioids." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="21991" end="21995" sStart="null" offset="209" sid="r9.fold.v.0060" wn="2147483646" wnkey="null" text="In the presence of the EGFR, ligand activation of LPA and ET-1 receptors did not increase EGFR phosphorylation even though both the LPA and ET-1 receptors stimulated ERK activity by 10-fold over basal [ 27 ] . Specifically, key protein intermediates may be physically associated with endogenous RTKs in HEK-293 cells, and therefore, down-regulation of the EGFR may negatively affect ERK phosphorylation by opioids." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="21991" end="21995" sStart="null" offset="209" sid="r9.fold.v.0060" wn="2147483645" wnkey="null" text="In the presence of the EGFR, ligand activation of LPA and ET-1 receptors did not increase EGFR phosphorylation even though both the LPA and ET-1 receptors stimulated ERK activity by 10-fold over basal [ 27 ] . Specifically, key protein intermediates may be physically associated with endogenous RTKs in HEK-293 cells, and therefore, down-regulation of the EGFR may negatively affect ERK phosphorylation by opioids." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="21991" end="21995" sStart="null" offset="209" sid="r9.fold.v.0060" wn="0" wnkey="null" text="In the presence of the EGFR, ligand activation of LPA and ET-1 receptors did not increase EGFR phosphorylation even though both the LPA and ET-1 receptors stimulated ERK activity by 10-fold over basal [ 27 ] . Specifically, key protein intermediates may be physically associated with endogenous RTKs in HEK-293 cells, and therefore, down-regulation of the EGFR may negatively affect ERK phosphorylation by opioids." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="170" end="176" sStart="null" offset="127" sid="r8.family.n.0616" wn="6" wnkey="family%1:14:03::" text="Opioid receptors (ORs), like many other G protein-coupled receptors (GPCRs), are capable of signalling via the family of mitogen activated protein kinases (MAPKs)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="14627" end="14636" sStart="null" offset="202" sid="null" wn="5" wnkey="different%5:00:01:other:00" text="The results presented, herein, strongly suggest that transactivation of RTKs does not make a significant contribution to DSLET-induced ERK activation in at least two different cell lines." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="14627" end="14636" sStart="null" offset="202" sid="null" wn="5" wnkey="different%5:00:01:other:00" text="The results presented, herein, strongly suggest that transactivation of RTKs does not make a significant contribution to DSLET-induced ERK activation in at least two different cell lines." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="14627" end="14636" sStart="null" offset="202" sid="null" wn="2" wnkey="different%5:00:00:other:00" text="The results presented, herein, strongly suggest that transactivation of RTKs does not make a significant contribution to DSLET-induced ERK activation in at least two different cell lines." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="21056" end="21065" sStart="null" offset="191" sid="r8.1.different.j.0239" wn="1" wnkey="different%3:00:00::" text=", unpublished observations), similar to what we previously reported for the ?-OR expressed in Chinese hamster ovary or HEK-293 cells [ 11 13 ] . Thus, in at least two different cell lines, HEK-293 and C6 glioma, we have significant evidence that transactivation of an endogenously expressed RTK is not required for ERK activation through opioid receptors." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="14825" end="14831" sStart="null" offset="115" sid="r10.common.j.0437" wn="1" wnkey="common%3:00:02::" text="With the first evidence that GPCRs could signal via the MAPK cascade, many investigators have looked for a common mechanism of activation that could be applied across receptor types." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="16002" end="16008" sStart="null" offset="87" sid="r10.common.j.0251" wn="3" wnkey="common%5:00:00:shared:00" text="Despite numerous reported differences, it does appear that diverse GPCRs share common mechanistic themes during ERK stimulation, including the tyrosine-phosphorylation of Shc and its complexing with Grb2, mSOS recruitment, the GTP-loading of Ras, and Raf-1 activation leading to MEK-1 phosphorylation [ 1 ] . However, the progression of each of these downstream events after GPCR stimulation depends first on the tyrosine phosphorylation of a membrane-bound protein that will be used as a scaffold, which will bind the other proteins (e.g." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-2-5.anc" start="7488" end="7495" sStart="null" offset="0" sid="null" wn="1" wnkey="become%2:30:00::" text="Our next experiments were designed to examine whether the EGFR &lt;b&gt;becomes&lt;/b&gt; tyrosine phosphorylated during ERK activation by DSLET." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-2-5.anc" start="7488" end="7495" sStart="null" offset="0" sid="null" wn="2" wnkey="become%2:42:01::" text="Our next experiments were designed to examine whether the EGFR &lt;b&gt;becomes&lt;/b&gt; tyrosine phosphorylated during ERK activation by DSLET." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="10758" end="10765" sStart="null" offset="22" sid="r9.appear.v.0193" wn="1" wnkey="appear%2:39:00::" text="This lack of response appears to be due to the down-regulation of EGFRs from these cells as confirmed by immunoblots using the anti-EGFR antibody (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="15962" end="15968" sStart="null" offset="47" sid="r9.appear.v.0391" wn="4" wnkey="appear%2:39:01::" text="Despite numerous reported differences, it does appear that diverse GPCRs share common mechanistic themes during ERK stimulation, including the tyrosine-phosphorylation of Shc and its complexing with Grb2, mSOS recruitment, the GTP-loading of Ras, and Raf-1 activation leading to MEK-1 phosphorylation [ 1 ] . However, the progression of each of these downstream events after GPCR stimulation depends first on the tyrosine phosphorylation of a membrane-bound protein that will be used as a scaffold, which will bind the other proteins (e.g." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="8056" end="8063" sStart="null" offset="136" sid="r9.appear.v.0486" wn="4" wnkey="appear%2:39:01::" text="Our laboratory has previously reported [ 11 13 ] that 5-opioids induce tyrosine phosphorylation of the ?-OR, and it appears that this is catalyzed by the non-receptor tyrosine kinase Src." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="3868" end="3875" sStart="null" offset="115" sid="r11.absence.n.0824" wn="1" wnkey="absence%1:26:00::" text="These data suggest that the tyrosine phosphorylation of GPCRs may allow them to signal ERKs in the absence of RTK or FAK phosphorylation by acting as their own scaffolds." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-2-5.anc" start="23616" end="23623" sStart="null" offset="105" sid="r11.absence.n.0272" wn="1" wnkey="absence%1:26:00::" text="In conclusion, we report that the ?-OR agonist, DSLET, induces significant ERK activation in the absence of any increase in phosphorylation of the co-expressed EGFR in HEK-293 cells." />
  </sentences>
</list>